In male sexual dysfunction
there are times when psychiatric care should be considered, particularly in patients with severe depression, substance-use disorders, or abusive and chaotic relationships.
Guay, cochairman of the AACE male sexual dysfunction
task force and director of the Center for Sexual Function at the Lahey Clinic Northshore, Peabody, Mass.
In further pursuit of the perfect penis: The comprehensive urology center and the medicalization of male sexual dysfunction
Other content additions or expansions cited by 2 or 3 programs included sexuality and disability, sexual orientation, and male sexual dysfunction
Read more inside Male Sexual Dysfunction
- Pipeline Review, H2 2011
Coverage of the Male Sexual Dysfunction
pipeline on the basis of therapeutic class, route of administration and molecule type.
An Overview of Pipeline Products for Male Sexual Dysfunction
So many treatments focus on male sexual dysfunction
, but there are very few treatments designed specifically to help women," said Vaisman.
The first-of-its-kind meeting comes in response to calls for gender equity in sexual health from tens of thousands of FSD patients, patient advocates, clinicians and women's rights activists through the Even the Score campaign, which was launched last summer by a diverse group of women's health and rights organizations after the FDA approved a 26th drug marketed to treat male sexual dysfunction
23, 2014 /PRNewswire-USNewswire/ -- More than 80 clinical experts specializing in male sexual dysfunction
today sent a letter to the Food and Drug Administration (FDA) applauding its decision to hold a two-day workshop next week focused on female sexual dysfunction (FSD), a condition the FDA has designated a priority unmet medical need.
1, 2014 /PRNewswire-USNewswire/ -- In the latest call for gender equity in the approval of treatments for sexual dysfunction, more than 60 doctors and leading medical experts from across the country have penned an open letter questioning the Food and Drug Administration's (FDA) decision to approve 26 drugs marketed for the most common form of male sexual dysfunction
compared with ZERO for women's most common complaint, and calling on the agency to act for women by approving the first-ever drug to treat Hypoactive Sexual Desire Disorder (HSDD), or low desire.
Both the DISF-SRII, a validated libido questionnaire and the Male Sexual Dysfunction
Survey (MSDS), a questionnaire focusing on distress associated with low testosterone, have been developed by Dr.